
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mOtCQc
via
IFTTT
0 comments:
Post a Comment